The newest clinically available technologies in 2026 include AI-guided laser treatment planning, the VISUMAX 800 for SMILE, the EVO+ ICL with central port, premium trifocal and EDOF IOLs, and the Light-Adjustable Lens. Several more are approaching FDA approval or entering early adoption.
The forward-looking full review is at The Future of Vision Correction Technology within the Vision Correction Procedures Compared hub.
Featured Snippet: Newest Technologies by Procedure Category
Laser refractive surgery:
- AI-guided treatment nomograms (improved accuracy to 95–98% within 0.50D)
- VISUMAX 800 (2 MHz pulse rate, improved SMILE astigmatism correction)
- Wavefront-guided topography-integrated ablation platforms
Phakic IOL:
- EVO+ ICL with central port (eliminates peripheral iridotomy requirement; reduced cataract risk)
Lens replacement:
- ALCON PanOptix trifocal IOL (FDA-approved 2019, now widely available)
- Johnson & Johnson TECNIS Synergy trifocal
- Alcon Vivity EDOF IOL
- RxSight Light-Adjustable Lens
In development:
- Trifocal and EDOF ICL designs (international clinical trials)
- PiXL (photorefractive intrastromal crosslinking — refractive correction without ablation)
AI-Guided Treatment Planning
The most widely adopted recent advance in laser refractive surgery is the integration of machine learning into surgical planning. Traditional LASIK and PRK planning uses the laser manufacturer’s nominal algorithm plus surgeon-specific nomogram adjustments based on accumulated experience.
AI-guided nomograms synthesize outcomes from large historical datasets — thousands of treated cases — to predict how a specific patient’s cornea will respond to a given treatment. Early published data show meaningful improvements in refractive accuracy: more patients landing within ±0.25D of the intended outcome, fewer enhancements, and better optical quality metrics.
This is not yet available at all practices, but it is becoming the new standard at technology-forward centers.
VISUMAX 800
The VISUMAX 800 is the current-generation SMILE platform from Carl Zeiss Meditec, succeeding the VISUMAX 500. Key improvements:
- Faster pulse repetition (2 MHz): Reduces procedure time from approximately 25–30 minutes to 15–20 minutes per eye.
- Improved astigmatism accuracy: Enhanced software for elliptical lenticule design and alignment aids.
- More comfortable interface: Smaller, lower-pressure contact glass.
For practices offering SMILE, confirming which VISUMAX generation they use is a reasonable quality question.
EVO+ ICL with Central Port
The EVO+ is the current production version of the EVO ICL. Its defining feature — the central port, a 360-micron aqueous flow channel through the optic — allows natural aqueous humor circulation without peripheral iridotomies (laser holes in the iris).
Previous ICL generations required iridotomies to prevent elevated intraocular pressure and the risk of cataract formation. The EVO+’s central port eliminates these risks through natural fluid dynamics. Post-market surveillance confirms cataract formation rates approaching background age-matched rates — a significant safety improvement over earlier designs.
Light-Adjustable Lens (RxSight LAL)
Approved by the FDA in 2017 and entering wider adoption since 2021, the RxSight LAL is a premium IOL whose refractive power can be non-invasively adjusted after implantation using UV light. Patients undergo 2–4 “adjustment” sessions in the weeks after surgery, with the final power locked in UV-protecting glasses are required until lock-in.
Clinical data show that LAL patients achieve significantly better refractive accuracy than patients receiving conventional monofocal IOLs — a meaningful advantage for patients with complex prescriptions, post-LASIK eyes, or those for whom standard IOL calculation has higher uncertainty.
What Is Coming Next
Near-term developments approaching adoption:
- Extended-range ICL designs (trifocal and EDOF optics in a phakic IOL format)
- PiXL — refractive correction via corneal stiffening rather than ablation
- Real-time adaptive laser systems (closed-loop ablation feedback during surgery)
See How Has Vision Correction Surgery Improved in Recent Years? for historical context, and The Future of Vision Correction Technology for the full forward-looking analysis.
Related Resources
- How Has Vision Correction Surgery Improved in Recent Years?
- What Is the Best Vision Correction Surgery?
- Which Vision Correction Is Safest?
*This content is educational and does not constitute medical advice. Technologies described as “in development” are not yet commercially available in all markets.*